(Q34774783)

4 August 2017

title

Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses (English)

1 reference

4 August 2017

0 references

6

Sina Bavari

1 reference

4 August 2017

2

Kelly L Warfield

1 reference

4 August 2017

Dana L Swenson

1

1 reference

4 August 2017

Tom Larsen

series ordinal

3

1 reference

4 August 2017

D Anthony Alves

series ordinal

4

1 reference

4 August 2017

Sadie S Coberley

series ordinal

5

1 reference

4 August 2017

publication date

1 May 2008

1 reference

Expert Review of Vaccines

4 August 2017

published in

1 reference

4 August 2017

volume

7

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

417-429

1 reference

Forty years of marburg virus

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Marburg virus vaccines: comparing classical and new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Vaccine research efforts for filoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Filovirus-like particles as vaccines and discovery tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Genomic differences between guinea pig lethal and nonlethal Marburg virus variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Marburg agent disease: pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Pathogenesis of experimental Ebola virus infection in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Molecular characterization of guinea pig-adapted variants of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Respiratory Marburg virus infection in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Pathological anatomy of the "Marburg virus" disease (the so-called "Marburg monkey disease")

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

Development of a model for marburgvirus based on severe-combined immunodeficiency mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.4.417

21 January 2018

Identifiers

DOI

10.1586/14760584.7.4.417

1 reference

4 August 2017

1 reference